Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
aTyr Pharma, Inc. is a biotechnology company focused on developing therapies for fibrosis and inflammation using its proprietary platform based on extracellular tRNA synthetase biology. Its lead candidate, efzofitimod, is a biologic immunomodulator targeting immune-mediated lung diseases like sarcoidosis and ILD. The company advances novel biologics, collaborates globally, and relies on third-party manufacturing, aiming to address unmet medical needs with innovative, mechanism-based treatments.
This description was generated via AI from an annual report. Updated about 1 year ago.